当前位置:首页 » 翻译 
  • 匿名
关注:1 2013-05-23 12:21

求翻译:Newer biologic agents in patients with moderate to severe plaque psoriasis are ustekinumab (an interleukin-12 and interleukin-23 blocker), brodalumab, an anti–interleukin-17 receptor antibody, and briakinumab, a monoclonal antibody against the p40 molecule shared by interleukin-12 and interleukin-23, which is overexpre是什么意思?

待解决 悬赏分:1 - 离问题结束还有
Newer biologic agents in patients with moderate to severe plaque psoriasis are ustekinumab (an interleukin-12 and interleukin-23 blocker), brodalumab, an anti–interleukin-17 receptor antibody, and briakinumab, a monoclonal antibody against the p40 molecule shared by interleukin-12 and interleukin-23, which is overexpre
问题补充:

  • 匿名
2013-05-23 12:21:38
较新的生物制剂的患者的中度至重度斑状银屑病是ustekinumab (一种白细胞介素-12和白细胞介素23受体阻滞剂) , brodalumab ,抗白介素17受体抗体,和briakinumab ,针对的p40分子的单克隆抗体由白介素共享
  • 匿名
2013-05-23 12:23:18
正在翻译,请等待...
  • 匿名
2013-05-23 12:24:58
正在翻译,请等待...
  • 匿名
2013-05-23 12:26:38
正在翻译,请等待...
  • 匿名
2013-05-23 12:28:18
正在翻译,请等待...
 
 
网站首页

湖北省互联网违法和不良信息举报平台 | 网上有害信息举报专区 | 电信诈骗举报专区 | 涉历史虚无主义有害信息举报专区 | 涉企侵权举报专区

 
关 闭